Our mission is to identify and invest in seed, first round, and early stage information technology and life science businesses with exceptional promise and help them grow into sustainable, market-leading companies. In addition, Polaris is committed to providing growth equity and shareholder liquidity to established companies in the technology, healthcare, manufacturing, media, communications, and business services sectors. As a national venture capital firm with offices in the high-tech centers of Boston and Seattle, we’re able to invest in businesses throughout the United States and around the world. The firm has over $3 billion under management and current investments in more than 90 companies.

Through our philosophy of lead investing and active, long-term partnering with early stage and growing revenue stage companies, the firm has helped a number of companies achieve outstanding success. Among them are Advanced Inhalation Research (AIR) (sold to Alkermes); Akamai Technologies, Inc. (NASDAQ: AKAM); Allaire Corporation (sold to Macromedia); Aspect Medical Systems (NASDAQ: ASPM); Centra Software (NASDAQ: CTRA); deCODE genetics (NASDAQ: DCGN); Paradigm Genetics, Inc. (NASDAQ: PDGM); and Solidworks (sold to Dassault Systemes).